The interaction between VLA-4 and vascular cell adhesion molecule-1 (VCAM-1) mediates binding between multiple myeloma cells and BMSCs, contributing to the survival of multiple myeloma cells via the activation of the PI3K/AKT pathway and CAM-DR [53,54]. This evidence concerns the gene AKT1 and plasma cell myeloma.